| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TRDA | Common Stock | Options Exercise | $16,884 | +8,040 | +39% | $2.10* | 28,756 | 25 Oct 2022 | Direct | F1 |
| transaction | TRDA | Common Stock | Sale | $101,462 | -4,942 | -17% | $20.53 | 23,814 | 25 Oct 2022 | Direct | F1, F2 |
| transaction | TRDA | Common Stock | Sale | $64,215 | -2,998 | -13% | $21.42 | 20,816 | 25 Oct 2022 | Direct | F1, F3 |
| transaction | TRDA | Common Stock | Sale | $2,213 | -100 | -0.48% | $22.13 | 20,716 | 25 Oct 2022 | Direct | F1 |
| transaction | TRDA | Common Stock | Options Exercise | $10,416 | +4,960 | +24% | $2.10* | 25,676 | 26 Oct 2022 | Direct | F1 |
| transaction | TRDA | Common Stock | Sale | $13,638 | -643 | -2.5% | $21.21 | 25,033 | 26 Oct 2022 | Direct | F1, F4 |
| transaction | TRDA | Common Stock | Sale | $95,021 | -4,317 | -17% | $22.01 | 20,716 | 26 Oct 2022 | Direct | F1, F5 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TRDA | Stock Option (Right to Buy) | Options Exercise | $0 | -8,040 | -6.3% | $0.000000 | 119,682 | 25 Oct 2022 | Common Stock | 25,033 | $2.10 | Direct | F1, F6, F7 |
| transaction | TRDA | Stock Option (Right to Buy) | Options Exercise | $0 | -4,960 | -4.1% | $0.000000 | 114,722 | 26 Oct 2022 | Common Stock | 20,716 | $2.10 | Direct | F1, F6 |
| Id | Content |
|---|---|
| F1 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2022. |
| F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.01 to $21.895, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F4 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.79 to $21.66, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F5 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.79 to $22.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F6 | 25% of the shares subject to this option shall vest and become exercisable on December 7, 2021, with the remaining 75% vesting in 36 equal monthly installments thereafter. |
| F7 | The Form 4 filed by the reporting person on September 12, 2022 inadvertently understated the number of shares remaining subject to this option following the transactions reported therein by 111,690 shares, an error that was carried forward onto the reporting person's subsequent Form 4 filings. Prior to the transactions reported herein, the correct number of shares remaining subject to this option was 127,722 shares. |